Apoptosis Pathway–Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma
Debora Alejandra Ledesma(The University of Texas MD Anderson Cancer Center), Carlos A. Torres‐Cabala(The University of Texas MD Anderson Cancer Center), Elsa M. Li-Ning-Tapia(The University of Texas MD Anderson Cancer Center), Phyu P. Aung(The University of Texas MD Anderson Cancer Center), Jonathan L. Curry(The University of Texas MD Anderson Cancer Center), Rossana Lazcano(The University of Texas MD Anderson Cancer Center), Miluska Castillo(Instituto Nacional de Enfermedades Neoplásicas), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Mario L. Marques‐Piubelli(The University of Texas MD Anderson Cancer Center), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Jun Gu(Peking University), Courtney W. Hudgens(The University of Texas MD Anderson Cancer Center), Wen‐Jen Hwu(The University of Texas MD Anderson Cancer Center), Alessio Giubellino(University of Minnesota)
Cited by 2
Related Papers
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
|New England Journal of Medicine|2019|1.4k
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2012|906
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
|Science|2021|876